Anne G. Wallice

ANNE WALLICE focuses her practice on advising large private and public companies, creditors, and investors in highly complex restructuring transactions. She has experience with corporate reorganization, bankruptcy, and other insolvency-related matters. Anne represents debtors, secured and unsecured creditors, and distressed investors and private equity funds, and provides strategic and practical advice to management teams and boards of directors regarding financially distressed situations.

Anne has experience in large-scale, cross-border restructurings and insolvencies involving the United States, Canada, Ireland, the United Kingdom, and the Cayman Islands and has advised clients in distressed situations across industries, including aviation, healthcare, energy, and retail.

Debtor Representations

• Special Restructuring Committee of Genesis Healthcare, Inc. in high-stakes bankruptcy litigation involving claims for equitable subordination, fraudulent transfer, and preference against a company insider. Following opening statements and evidentiary hearings at trial, secured a landmark settlement providing approximately US$640 million in combined benefit to the estate, including a US$150 million payment and waiver of approximately US$490 million in debt claims.
• Vi-Jon, LLC, an American personal care company and the oldest private label manufacturer in the United States, in its prearranged Chapter 11 bankruptcy case in the United States Bankruptcy Court for the District of Delaware.
• United Airlines in connection with the proposed merger of Republic Airways and Mesa Airlines.
• AerCap Ireland Limited in connection with the GOL Linhas Aéreas Inteligentes S.A. Chapter 11 cases.
• Prospect Medical Holdings, Inc. (Prospect) and several of its subsidiaries in its Chapter 11 cases in the United States Bankruptcy Court for the Northern District of Texas. With over US$2.3 billion in outstanding funded debt, Prospect’s Chapter 11 cases are among the largest filed in 2025.
• Eiger Biopharmaceuticals, Inc., a Palo Alto, California-based biopharmaceutical company that developed treatments for rare metabolic diseases, in its Chapter 11 cases in the U.S. Bankruptcy Court for the Northern District of Texas through three successful asset sales and a consensual plan of liquidation, resulting in the prepetition secured lender and unsecured creditors being paid in full and distributions being made to equity.
• Accelerate Diagnostics, Inc., an innovative diagnostic testing company, in the out-of-court restructuring of its matured bond debt.
• Amerijet International Airlines and certain of its affiliates and subsidiaries in connection with their comprehensive financial and operational out-of-court restructuring.
• Envision Healthcare Corp. and its 216 debtor subsidiaries in their prearranged Chapter 11 restructuring in the U.S. Bankruptcy Court for the Southern District of Texas.
• Nordic Aviation Capital Designated Activity Company and its 116 debtor subsidiaries in their prearranged Chapter 11 restructuring in the U.S. Bankruptcy Court for the Eastern District of Virginia.
• Mood Media Corporation and its affiliates in their prepackaged Chapter 11 restructuring in the U.S. Bankruptcy Court for the Southern District of Texas.
• Tailored Brands, Inc. and its 17 affiliates in their prearranged Chapter 11 cases in the U.S.  Bankruptcy Court for the Southern District of Texas.

Some of the above matters were handled prior to joining Sidley.